Doha, Qatar: The opening of the Medical Care and Research Center (MCRC) exemplifies Hamad Medical Corporation's (HMC) ongoing commitment to enhancing healthcare services and increasing the capacity to provide specialized care to the highest global quality standards for all patients. The new 250-bed center offers an excellent healing environment for inpatients and is one of the initiatives aimed at promoting therapeutic practices through clinical precision medicine and genomics. The Center will offer medical treatments that are developed based on the individual characteristics of each patient, allowing doctors and researchers to more accurately identify the best treatment strategies for a particular disease, enhancing the effectiveness of treatments and reducing the risks of adverse reactions.
The MCRC, HMC’s newest facility, aims to support and conduct clinical trials in the field of precision medicine and to provide access to precision care across all major and sub-specialties offered by HMC. The Center supports researchers and clinicians in conducting research and clinical trials with a primary focus on patient safety, leading to significant improvements in patient care and outcomes. Located at Hamad Bin Khalifa Medical City in Doha, the Medical Care and Research Center consists of four floors plus the ground floor and includes several single and shared patient rooms, isolation rooms and a seating and mobility clinic.
The MCRC is also connected via an internal bridge to t.
